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Purpose: To establish a cornea transplant model in a pigmented rat strain and to define the immunologic reaction toward
corneal allografts, by studying the cellular and humoral immune response after keratoplasty.
Methods: Full thickness penetrating keratoplasty was performed on Brown Norway (RT1n) recipients using fully major
histocompatibility  complex  (MHC)-mismatched  Piebald-Viral-Glaxo  (PVG;  RT1c)  donors.  Using  multicolor  flow
cytometry (FACS) we quantified and compared the cellular composition of draining versus non-draining lymph nodes
(LN). Furthermore, we developed an isolation method to release viable graft infiltrating lymphocytes (GIL) and subjected
them to phenotypic analysis and screened serum from transplanted animals for allo-antibodies.
Results: Assessing ipsi-lateral submandibular LN we find ample evidence for post surgical inflammation such as elevated
absolute numbers of cluster of differentiation (CD)4+, CD8+, B-cells, and differential expression of CD134. However, we
could not unequivocally identify an allo-antigen-specific immune response. FACS analysis of lymphocytes isolated from
collagenase digested rejected corneas revealed the following six distinct subpopulations: MHC-2+ cells, CD4+ T-cells,
CD8+ T-cells, CD161dull large granular lymphocytes, CD3+ CD8+ CD161dull natural killer (NK)-T-cells and CD161high
CD3- NK cells. At post-operation day (POD)-07 only CD161dull MHC-2neg large granular lymphocytes (LGLs) were
detected in syngeneic and allo-grafts. In concordance with an increase in B-cell numbers we often detected copious
amounts of allo-antibodies in serum of rejecting animals, in particular immunoglobulin (Ig) M (IgM), immunoglobulin
(Ig) G1 (IgG1), and IgG2a.
Conclusions: Our results demonstrate that despite its immune privileged status and low-responder characteristics of the
strain combination, allogeneic corneal grafts mount a full fledged T helper1 (Th1) and Th2 response. The presence of
NK-T-cells and NK-cells in rejecting corneas shows the synergy between innate and adaptive immunity during allograft
destruction.
Animal models of penetrating keratoplasty have been
valuable research tools for our understanding of allo-rejection
processes in the context of an immune privileged site [1]. The
cellular key players and the corner stones of the rejection
pathways have been elucidated [2]. The cervical lymph nodes
(LN) have been unequivocally identified as the location where
the allo-recognition of corneal grafts is concentrated [3-6]. So
far  indirect  in-vitro  methods  have  been  used  to  identify
specific T-cell responses mounted against allogeneic corneal
transplants [7]. We hypothesized that by adopting a multi-
parameter flow cytometry (FACS) approach to both identify
and quantify lymphocyte populations in the draining lymph
nodes and to screen for T-cell activation markers, it would be
possible to directly assess allo-reactive T-lymphocytes and
define  the  characteristics  of  our  transplant  model.  We
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specifically chose a rarely used low responder model to study
the rejection process [8] and sought to determine whether
previous results from high responder strain combinations such
as Lewis-Brown Norway (LEW-BN) or Lewis-Dark Agouti
(LEW-DA) can be reproduced.
Of particular interest to us was the determination of graft
infiltrating lymphocytes. In the past immuno-histochemistry
(IHC)  was  the  method  of  choice  to  identify  the  different
immune cells [9-11]. However, IHC is difficult to establish
and in general laborious, effectively limiting the number of
samples  processed  and  the  application  of  multi-parameter
analysis. Additionally, results are often difficult to interpret
and are prone to subjective bias. Instead, we developed a
digestion procedure, which releases viable cells from corneal
tissue.  To  demonstrate  the  effectiveness  of  this  novel
approach  we  used  multicolor  FACS  to  describe  the  cells
involved in the graft destruction process.
METHODS
Animals: All procedures performed were conducted under
animal license number B100/3852 and were approved by the
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420Animals  Ethics  Committee  of  the  National  University  of
Ireland, Galway. In addition, animal care and management
followed the Standard Operating Procedures of the Animal
Facility at the National Centre for Biomedical Engineering
Science.  Brown  Norway  (BN,  RT1n)  and  Piebald-Viral-
Glaxo  (PVG,  RT1c)  rats  were  purchased  from  Harlan
Laboratories UK and housed under specific pathogen free
conditions with food and water ad lib.
Keratoplasty  model:  A  low-risk  fully  allogeneic  major
histocompatibility  complex-1  (MHC-1/MHC2  and  non-
classical MHC) with BN as recipient and PVG as donor was
established. All animals were male and of 8–14 weeks age.
Anesthesia: Isoflurane was administered systemically at 2%–
2.5% in medical oxygen (BOC, Galway, Ireland) with a flow
rate  of  2  l/min.  Local  anesthesia  was  performed  with
Tetracaine  1%  (Chauvin  Pharmaceuticals  Ltd.,  Kingston-
upon-Thames  ,  UK).  Iris  dilation  was  performed  with
Atropine 1%, Tropicamide 1% and Phenylephrine 2.5% (all
Chauvin Pharmaceuticals Ltd.). A 3 mm full thickness graft
was placed on a 2.5 mm graft bed, fixed with 8–10 interrupted
10–0 Ethilon® sutures (Ethicon, Livingston, Scotland) and
covered  with  chloramphenicol  antibiotic  ointment.  Alcon
BSS® (Alcon, Hemel Hempstead, UK) was used for irrigation
of cornea tissue. Eyelids stayed open post-op and the sutures
were not removed. Graft appearance was assessed every other
day and the opacity graded according to the following scale
modified for pigmented iris: 0-no opacity; 1-minimal-all iris
details (crypts) visible; 2-some iris details visible; 3 strong-
only pupil margin visible; 4 complete-anterior chamber not
visible. An opacity ≥3 was considered rejected.
Flow-cytometry:  Information  on  primary  antibodies  and
appropriate isotype controls are presented in Table 1. Staining
was  performed  according  to  standard  protocols  including
Fcγ-block, live/dead stain (violet Live/Dead; Invitrogen, Dun
Laoghaire,  Ireland)  and  endogenous  biotin  blocking
(Molecular Probes (division of Invitrogen) Dun Laoghaire,
Ireland).  Flowcytometric  data  was  acquired  and  analyzed
according to principles laid out in detail by Herzenberg et al.
[12].
Isolation of lymphocytes from draining LN and corneal tissue:
Lymph  nodes  and  corneas  were  digested  with  5%  w/v
Collagenase D (Roche Diagnostics Ltd, Burgess Hill, UK) in
RPMI containing 25 mM HEPES (Lonza Wokingham, Ltd.,
Berkshire,  UK)  plus  1%  fetal  calf  serum  (Sigma-Aldrich
Ireland Ltd.; Dublin, Ireland) at 37 °C. Cornea specimens
were agitated on an Eppendorf Thermomixer® R (Eppendorf
UK Limited, Cambridge, UK) for 90 min at 900 per minute
mixing frequency during the digestion reaction. LNs were
incubated for 30 min under the same conditions. The digestion
reaction was stopped by adding an excess volume of cold PBS
+2mM  EDTA  (Lonza  Wokingham,  Ltd.).  Remaining
undigested tissue was carefully poured into a 100 µM cell
strainer and disintegrated with the plunger of a syringe. Cell
suspensions were collected in 6 cm tissue culture dishes then
transferred into 15 ml tubes spun at 400× g for 4 min and
washed again with PBS+2 mM EDTA. Individual cornea
TABLE 1. ANTIBODIES USED FOR FLOW-CYTOMETRY.
Name Isotype Clone Host Label Supplier code Supplier
CD3 IgG3aκ G4.18 mouse PE 554833 BD Biosciences
CD3 IgG3aκ G4.18 mouse FITC 11-0030-82 eBioscience
CD4 IgG2aκ Ox-35 mouse APC 17-0040 eBioscience
CD8 IgG1 Ox-8 mouse Biotin MCA48B Serotec
CD8 IgG1 Ox-8 mouse AF647 MCA48AF647 Serotec
CD25 IgG1 Ox-39 mouse FITC 554865 BD Biosciences
CD32 Fc-γ Block IgG1 D34-485 mouse NALE 550271 BD Biosciences
CD45RA IgG1 Ox-33 mouse FITC MCA430F Serotec
MHC-2 IgG1 Ox-6 mouse PE MCA46PEB Serotec
CD134 IgG1 Ox-86 mouse PE MCA1420PE Serotec
CD161 IgG1 10/78 mouse PE 555009 BD Biosciences
CD161 IgG1 10/78 mouse Biotin MCA1427B Serotec
IgM IgG1 G53-238 mouse PE 553888 BD Biosciences
Isotype control antibodies
Isotype control IgG1 F8-11-13 mouse Biotin MCA1209B Serotec
Isotype control IgG1 F8-11-13 mouse PE MCA1209PE Serotec
Isotype control IgG1 F8-11-13 mouse AF647 MCA1209A647 Serotec
Isotype control IgG1 MOPC-21 mouse FITC 555909 BD Biosciences
Isotype control IgG2aκ - mouse APC 17-4724 eBioscience
Isotype control IgG3aκ A112-3 mouse PE 559929 BD Biosciences
Isotype control IgG3aκ B10 mouse FITC 11-4742-73 eBioscience
Secondary reagents
Sav-PerCP-Cy5.5 551419 BD Biosciences
Sav-PE-Cy7 557598 BD Biosciences
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stainings.
Serum analysis: Blood was collected by cardiac puncture and
left to coagulate for serum harvesting. Diluted serum (1:5) was
incubated with Piebald-Viral-Glaxo (PVG) splenocytes for 30
min and then stained with either anti-rat IgM [G53–238] or
IgG1 [MRG1–58] or IgG2a [MRG2a-83] or IgA [MARA-1]
(all  from  Antibodies-online  GmbH,  Aachen,  Germany).
Positive control sera were generated by immunising naïve BN
rats with 1×106 γ-irradiated (12 Gy) thymic dendritic cells.
Thymic  dendritic  cells  (DCs)  were  obtained  by  density
gradient centrifugation (14.5% w/v Nycodenz® [Axis-Shield
UK,  Cambridgeshire,  UK])  according  to  the  method
published by Milling et al. [13]. Positive sera were harvested
14 days post immunization.
Flow-cytometry  equipment  and  software:  FACSAria-1,
FACSAria-2 and FACSCanto (BD Biosciences, Oxford, UK);
Acquisition  software  was  FACSDiva  V5  and  V6  (BD
Biosciences). Analysis software was Flowjo V7.6 for PC,
(Treestar, Inc., Ashland, OR).
Statistics: Non-parametric Mann–Whitney-U test was used
throughout  the  statistical  analysis.  A  p-value  ≤0.05  was
deemed  statistically  significant  and  indicated  where
appropriate.
Figure 1. Rejection kinetics of corneal
allografts  in  the  BN-PVG  strain
combination. A: An example of a well
healed corneal allograft approximately
day  21.  B:  Typical  appearance  of  a
rejected PVG allograft, arrow indicates
epithelial  rejection  line  (occasionally
observed). C: Rejection kinetics of the
BN-PVG strain combination BN-PVG
n=15,  BN-BN  n=9.  Kaplan–Meier-
Survival plot.
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General  characteristics  of  the  BN-PVG  model:  Figure  1
summarizes the basic parameters for the newly developed
cornea transplant model. PVG allo-grafts are rejected between
day  14  and  27  post  surgery  (mean=18.64+/−4.8  SD;
median=16  excluding  long-term  survivors;  median=21
including long-term survivors). Approximately 25% of all
grafted corneas are spontaneously accepted. Fibrin deposits
were common post-operatively but resolved spontaneously
after  four  days.  Neovascularisation  originating  from  the
limbus was very pronounced and typically reached the graft
by day seven to nine post-operation day (POD). Occasionally,
we observed endothelial and epithelial rejection lines (Figure
1B) during the rejection process.
FACS analysis of draining lymph nodes:
Quantitative  analysis  of  lymphocyte  populations—
We analyzed actively allo-rejecting animals and found that
the ipsi-lateral submandibular (i-SM) lymph node (LN) was
swollen and discolored (alloTx-rej, n=5). Using a multicolor
staining approach we measured the cellular composition of
that draining ipsi-lateral-SM LN. Moreover, we calculated the
relative  and  absolute  cell  numbers  of  minor  and  major
lymphocyte populations and compared these results with the
contra-lateral submandibular (c-SM) LN. We also chose a
distal contra-lateral brachial (d-Br) LN as reference to control
for the possibility that the contra-lateral LN participates in the
allo-rejection  due  to  its  close  proximity  to  the  primary
draining  lymph  nodes.  We  performed  this  procedure  on
lymphatic tissue isolated from rejecting animals as well as
from  syngeneically  grafted  long-term  survivors  (day  42,
synTx-LT, n=3). Additionally we analyzed an earlier time
point (POD-07) from allo- and syn-grafted rats (alloTx-d07,
n=6 or synTx-d07, n=3, respectively). First, from the data
presented in Figure 2 (upper bar diagrams) one can deduce
that  the  submandibular  LNs  in  general  have  a  strikingly
different cellular composition than distal brachial LNs. B-
cells are the dominant cell population which can be seen in all
study groups. We routinely find elevated cell numbers in the
draining  ipsi-lateral  LN  (i-SM)  of  transplanted  animals
compared to the contra-lateral side due to swelling, although
no  discernable  difference  between  the  groups  alloTx-d07,
alloTx-rej, and synTx-d07. From these data we conclude that
changes in lymphocyte composition are largely a result of the
surgical  trauma  and  the  local  inflammation  that  ensued
afterwards,  regardless  of  the  MHC  status  of  the  graft.
Concomitant  to  the  analysis  of  major  lymphocyte
compartments the data on minor lymphocyte populations is
shown in Figure 2, lower bar diagrams. In relative terms we
observed a reduced frequency of CD4+CD8+ double positive
T-cells (DP) in allo-recipients (alloTx-d07 and alloTx-rej) and
syngeneically  grafted  animals  on  POD-07  compared  to
syngeneic long-term survivors (Figure 2 3rd bar diagram from
top).  Further  a  small  increase  in  NK  cell  percentages  is
noticeable  in  actively  rejecting  study  animals  (arrows  in
Figure 2). There is, however, no difference between allo- and
syngeneically grafted animals on POD-07.
T-cell  activation  markers—To  identify  T-cell
activation characteristics for allo-graft rejection we screened
T-lymphocyte  subpopulations  (CD4+  SP  and  CD4+CD8+
DP)  for  the  expression  of  activation  markers  CD25  and
CD134 (Ox-40). Comparing syn-grafted long-term survivors
(synTx-LT) with early post-op groups (POD-07) and rejecting
animals  reveals  a  modest  relative  increase  in  CD25  and
CD25+CD134 co-expression in CD4+ single positive cells for
the latter three groups (synTx-d07, alloTx-d07, and alloTx-
rej,  respectively;  Figure  3  top  bar  diagram).  CD134  cell
surface density is elevated on cells in draining ipsi-lateral LN
(i-SM)  of  alloTx-d07  rats  compared  to  actively  rejecting
animals.  However,  the  same  relative  increase  in  CD134
expression is observed in synTx-d07 control animals (Figure
3, upper bar diagrams). Further, we used the same cell surface
marker  combination  to  analyze  the  small  subset  of
CD4+CD8+  DP  T-cells  and  find  statistically  significant
differences between allogeneically and syngeneically grafted
animals (Figure 3, lower diagrams). A much stronger CD25
expression can be observed on allo-grafted animals at POD-
07 and the day of rejection in contrast to iso-grafted animals
on POD-07 and long-term survivors. Moreover, we saw an
increase  of  CD25  CD134  double  expression  in  actively
rejecting study subjects compared to syngeneically    grafted
animals at the end of the observation period. In summary some
evidence for an allo-specific immune response was collected.
FACS analysis of graft infiltrating lymphocytes—To
add  to  the  comprehensive  analysis  of  the  BN-PVG  graft
rejection process, we also studied lymphocyte populations
which infiltrated the allograft (Figure 4). For that purpose we
developed  a  gentle  digestion  procedure  to  quickly  isolate
lymphocytes from transplanted corneas. By performing multi-
parameter flow cytometry on individual corneal preparations
we  were  able  to  identify  six  distinct  cell  populations
infiltrating a rejecting graft in this model. We found that CD4+
T-cells  represent  the  largest  single  fraction,  of  which
approximately  50%  are  CD25  positive  and  a  small
subpopulation of CD4 and MHC-2 positive cells. Further, we
can detect CD8+ T-cells as well as CD8+ CD161dull NK-T-
cells and CD8+/− CD161high CD3- NK cells. The latter two
cell-types constitute almost 50% of all GIL. Additionally, we
observed a large granular cell type with CD161dull expression.
These cells did not stain MHC-2 positive (determined by
back-gating  strategy)  and  could  already  be  detected  at
POD-07 in allogeneic and syngeneic grafts (Figure 4A,B).
Serum  analysis—To  complete  the  comprehensive
analysis of the model we collected serum from all animals in
the study and screened it for the presence of allo-antibodies.
As Figure 5 shows, we find evidence for the presence of anti-
PVG IgM, IgG1, and IgG2a immunoglobulins which directly
bind  allogeneic  target  cells  (PVG-splenocytes).  Allo-
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did not exhibit anti-donor antibody responses.
DISCUSSION
We  find  the  BN-PVG  rat  strain  combination  to  be  an
exceptionally  robust  model  with  little  intra-  and  post-
operative complications, which makes it an ideal choice for
pre-clinical studies. Furthermore, we find that this model with
its delayed rejection kinetics, rate of spontaneous acceptance
and occurrence of rejection lines more closely mimics the
clinical situation in humans (Figure 1) [14].
Analysis of draining lymph nodes: We found that the ipsi-
lateral  submandibular  LN  was  inflamed  as  a  result  of
allogeneic  penetrating  keratoplasty.  However,  signs  of
inflammation in the draining submandibular LN are largely
indistinguishable from inflammation caused by the surgical
trauma in syngeneic recipients and the resulting breach of the
immunological barrier of the eye (Figure 2).To detect allo-
primed T-cells we chose classical activation markers CD25
and CD134 because they perform excellently when studying
in-vitro cultures of allo-activated T-cells (M.M. and T.R.,
unpublished).  We  expected  a  certain  amount  of  T-cell
Figure 2. Qualitative and quantitative flow cytometric analysis of lymphocyte populations in draining lymph nodes. A: Representative FACS
plot of CD4+ CD8+ staining used to count T-helper cells, cytotoxic T-cells and CD4+ CD8+ double positive T-lymphocytes. Events acquired:
2×105. B: FACS plot example for B-cell detection. C: Representative FACS plot for NK cell assessment. NK-T cell were confirmed by CD3
expression (not shown). Bar diagrams: Cumulative results for the quantification of major and minor lymphocyte populations in draining LN
of cornea transplanted animals. An asterisk (*) indicates statistical significance at p≤0.05 determined by Mann–Whitney U-Test. Allo-Tx-d7
- animals allo-grafted and analyzed at day 07 post op, n=6; allo-Tx-rej – animals displaying allo rejection of grafted corneas analyzed after
the onset of rejection, n=5; syn-Tx-d7– syngeneically grafted  animals analyzed  at day 7 post-op, n=3; syn-Tx-LT –  syn-grafted    long-term
survivors analyzed at the end of the observation period at day 42; n=3.
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processes in non-sterile animals and regulatory T-cells with a
persistent activated phenotype, hence our choice to focus on
an inflamed lymph node rather than the spleen and blood.
Contrary to our expectations we find no unambiguous pattern
of allo-specific activation in draining LN (Figure 3). From that
we conclude, that the number of allo-antigen-specific T-cells
is dwarfed by bystander activation of helper T-cells due to the
surgical trauma and the normal background of activated T-
lymphocytes due environmental antigens. Some evidence for
an allo-specific immune response stems from the observation
of increased frequencies and absolute numbers of CD4+CD8+
double positive T-cells in ipsi-lateral draining LN of allo-
grafted recipients. CD8alpha expression on CD4+ T-cells is
not observed in mice. It is however a feature of rat and human
CD4+  T-lymphocytes  and  is  considered  as  an  activation
marker [15,16]. Kenny et al. [17] determined that this peculiar
subpopulation is dominated by Th1 helper T-cells. Given the
Figure 3. Flow cytometric analysis of helper T-cell activation markers in draining lymph nodes. A: Representative FACS plot of activation
marker expression on CD4+ single positive T-helper cell in draining LN. Events acquired: 2×105. B: Example of CD25 and CD134 expression
pattern on CD4+CD8+ double positive T-cells. Bar diagrams: Cumulative results for the quantification of T-cell activation status of Helper
T-lymphocytes. An asterisk (*) indicates statistical significance at p≤0.05 determined by Mann–Whitney U-Test.
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with regard to CD25 expression in CD4+CD8+DP cells, we
hypothesize that truly allo-antigen-specific T-cells may be
found in that compartment.
Allo-antibody serum analysis: Despite the obvious signs
of  an  immune  response,  the  graft  rejection,  we  aimed  at
establishing more parameters by which an allo-antigen driven
immune reaction can be detected. We found that a serum
analysis  accomplishes  this  task.  Since  spontaneous  graft
accepters do not form allo-antibodies a serum analysis is a
good  proxy  parameter  for  the  allo-rejection  process.
Particularly intriguing is the observation of anti-donor IgG2a
antibodies.  Despite  the  strong  apparent  Th2-type  bias  we
inferred from the massive presence of B-cells in the draining
submandibular LN and the presence of IgG1 isotypes, a Th-1
immune  response  must  have  occurred,  which  provided
interferon-γ for the antibody class switch from IgG1 to IgG2a
[18]. In contrast to other cell types B-cells and allo-antibodies
do  not  garner  much  attention  in  the  context  of  allo-graft
rejection.  Complement  and  antibodies  can  be  detected  in
human aqueous humor [19], and allo-antiserum from rejecting
animals has been found to confer complement dependent as
well as independent cytolysis [20,21]. Interestingly, antigen-
presenting B-lymphocytes also appear to play a significant
Figure 4. Flow cytometric analysis of graft-infiltrating lymphocyte populations. A, B: Allo-grafted cornea analyzed at day 7 post-op. A:
Forward-sideward scatter morphology of graft infiltrating cells. B: Representative image of CD161dull expression on LGL. No other cell type
could be detected. Recorded events: 2–5×103. C-H: FACS results of allo-rejecting corneas: Events acquired: 5×103 to 3×104 per sample. C:
FSC-SSC  morphology  of  GIL.  D:  Detection  of  T-lymphocytes.  E:  Measurement  of  CD8  and  CD161  NK  markers  on  GIL.  F:  Sub-
characterization of CD4+ T-cells and MHC-2 detection. G: Expression pattern of CD3 from populations gated in E. H: Measurement of CD25
T-cell activation markers on populations gated in D. Cut-off or positive CD25 expression was determined by measuring isotype FMO samples
on lymphocytes in draining LN from the same animal. For scaling reasons data are not shown in histogram. Bar diagram: Summary of all
lymphocyte specimens identified in rejected corneas (left diagram) and appropriate sub-characterizations (right diagram) n=5.
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cornea by inducing CD8+ suppressor T-cells [22].
Graft infiltrating lymphocytes: Collagenase digestion as
a method to isolate lymphocytes has been used previously in
mouse  studies  of  inflamed  corneas  [23].  However,  the
technique has not been applied on allo-grafted tissue so far.
FACS measurements of the corneal rejection process have so
far only been performed on aqueous humor samples in rat and
human [10,24]. Using our rapid digestion protocol for corneas
and the subsequent FACS analysis of isolated cells we can
confirm the presence of CD25 positive and negative CD4+
helper T-cells and CD8+ cytotoxic T-lymphocytes. Moreover,
we could demonstrate that the often observed NK-marker
CD161 [10,11] is expressed on three distinct cell populations.
In fact the majority of CD8+ expressing cells are either NK-
T-cells  or  CD3-  NK  cells.  We  further  identified  a  cell
population  with  a  CD161dull  phenotype,  which  is  already
present at day POD-07 in syngeneically and allogeneically
grafted animals. Due to this observation it is possible that
previous  IHC  studies  have  overestimated  the  number  of
infiltrating  natural  killer  cells.  We  assume  these  cells  to
activated  monocytes  as  described  by  Scriba  et  al.  [25].
Whether these cells are identical to ED2+ macrophages as
reported  by  Larkin  et  al.  [9]  remains  to  be  determined.
Figure 5. Serum allo-antibody measurement in grafted animals. Bar diagram: Summary of allo-antibody screening in transplanted animals
using a FACS based direct detection method. The presence of IgG1 infers a Th2 response, while the presence of IgG2a antibodies indicates
a Th1-IFN-γ induced class switch in B-cells. For IgM detection IgM+ B-cell were excluded from analysis by CD45RA staining (see Figure
2B); IgA isotypes could not be detected. FACS plots: Display of the measurement method for direct binding of allo-antibodies to allogeneic
target cells (PVG donor splenocytes); negative controls: serum from PBS injected animals harvested after day 14, positive controls: serum
from animals injected with 1×106 γ-irradiated thymic dendritic cells collected after day 14.
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importance  in  the  uptake  of  allogeneic  material  and  the
initiation of an allo-antigen-specific immune response. It has
been shown that, when monocyte infiltration into the graft is
blocked  by  a  toxic  drug  [26]  allo-graft  rejection  can  be
completely prevented.
Except for the few instances where CD161+ cells were
isolated from aqueous humor and were shown to have lytic
capacities  against  allogeneic  target  cells  [10],  functional
assays on GIL have not been performed so far. Our novel
isolation  method  of  GIL  allows  FACS  sorting  of  viable
lymphocytes and might contribute greatly in answering the
question of the precise graft destruction process. In general
our findings of graft infiltrating lymphocytes are in good
agreement with results previously obtained by IHC [9-11,
27].  A  putative  limitation  of  this  experimental  approach
should  be  mentioned  though.  We  can  not  exclude  the
possibility that strongly adherent cells such as Langerhans
cells and macrophages are not isolated in sufficient numbers.
Thus, our results obtained might be skewed toward higher
frequencies of non-adherent lymphocytes.
To  conclude,  our  results  demonstrate  that  despite  its
immune  privileged  status  and  the  low-responder
characteristics of the strain combination, allogeneic corneal
grafts mount a full fledged Th1 and Th2 immune response
similar  to  high  responder  strain  combinations.  The
idiosyncrasies of different strain combinations with regard to
rejection speed are not understood in general. The immune
response that we measured in the BN-PVG strain combination
appears to be normal. With the exception of T-cell activation
pattern, for which there is no comparable data set, the different
facets  of  the  allo-rejection  process  that  we  describe  here
appear to be identical to high responder strain combinations.
The  adaptive  immune  response  against  allogeneic
corneal  tissue  has  been  well  established  in  the  shape  of
indirectly primed allo-antigen specific CD4+ helper T-cells
[7,28]. However, CD4 knockout mice still reject allogeneic
corneas, albeit in a delayed fashion [29]. Furthermore, baby
rats with an immature adaptive immune system readily reject
fully mismatched corneal grafts and the accelerated rejection
is accompanied by increased numbers of graft infiltrating NK
and NK-T-cells [30]. The existence of alloreactive NK and
NK-T-cells has been established in rat and human cornea
transplant settings [10,24]. We hypothesize that the presence
of NK-T-cells and NK-cells in rejecting corneas shows the
synergy  between  innate  and  adaptive  immunity  during
allograft destruction, whereby the adaptive arm of the immune
system triggers and boost the host immune reaction but the
actual graft destruction is mediated by alloreactive NK and
NK-T-cells according to the ‘missing self hypothesis’ [31].
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